Birdwatch Note
2023-04-01 14:54:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The 2015 Nobel prize was given to researchers whose worked involved using ivermectin to treat parasitic (not viral) infections - not to the drug itself. Many studies at this point have shown ivermectin is not effective as a COVID-19 treatment https://www.reuters.com/article/factcheck-nobel-ivermectin/fact-check-2015-nobel-prize-for-ivermectin-intended-for-treatment-of-parasitic-infections-doesnt-prove-its-efficacy-on-covid-19-idUSL1N2QB2XA
Written by 7394A0B2A11FFC596FEAADA02244581A351EACEEC9F70F069BF7E43A1C9D7015
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1642174935987634178
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1642178656255500288
- noteId - 1642178656255500288
- participantId -
- noteAuthorParticipantId - 7394A0B2A11FFC596FEAADA02244581A351EACEEC9F70F069BF7E43A1C9D7015 Participant Details
- createdAtMillis - 1680360876513
- tweetId - 1642174935987634178
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The 2015 Nobel prize was given to researchers whose worked involved using ivermectin to treat parasitic (not viral) infections - not to the drug itself. Many studies at this point have shown ivermectin is not effective as a COVID-19 treatment https://www.reuters.com/article/factcheck-nobel-ivermectin/fact-check-2015-nobel-prize-for-ivermectin-intended-for-treatment-of-parasitic-infections-doesnt-prove-its-efficacy-on-covid-19-idUSL1N2QB2XA
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-01 14:54:36 UTC (1680360876513) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-02 02:40:17 UTC (1680403217809) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-04-01 19:17:30 -0500 | Rating Details | |
2023-04-01 16:52:57 -0500 | Rating Details | |
2023-04-01 16:40:38 -0500 | Rating Details | |
2023-04-01 16:07:29 -0500 | Rating Details | |
2023-04-01 15:59:32 -0500 | Rating Details | |
2023-04-01 15:42:04 -0500 | Rating Details | |
2023-04-01 15:37:25 -0500 | Rating Details | |
2023-04-01 15:03:46 -0500 | Rating Details | |
2023-04-01 14:51:16 -0500 | Rating Details | |
2023-04-01 14:48:26 -0500 | Rating Details | |
2023-04-01 14:45:27 -0500 | Rating Details | |
2023-04-01 14:44:07 -0500 | Rating Details | |
2023-04-01 14:22:59 -0500 | Rating Details | |
2023-04-01 14:15:43 -0500 | Rating Details | |
2023-04-01 13:52:38 -0500 | Rating Details | |
2023-04-01 13:52:08 -0500 | Rating Details | |
2023-04-01 13:39:47 -0500 | Rating Details | |
2023-04-01 13:39:30 -0500 | Rating Details | |
2023-04-01 13:32:37 -0500 | Rating Details | |
2023-04-01 13:31:46 -0500 | Rating Details | |
2023-04-01 12:51:10 -0500 | Rating Details | |
2023-04-01 11:03:05 -0500 | Rating Details | |
2023-04-01 11:01:33 -0500 | Rating Details | |
2023-04-01 10:48:32 -0500 | Rating Details | |
2023-04-01 10:45:40 -0500 | Rating Details | |
2023-04-01 10:45:02 -0500 | Rating Details | |
2023-04-01 10:20:07 -0500 | Rating Details | |
2023-04-01 10:00:13 -0500 | Rating Details | |
2023-04-01 09:58:17 -0500 | Rating Details | |
2023-04-01 20:08:19 -0500 | Rating Details | |
2023-04-10 18:34:41 -0500 | Rating Details | |
2023-04-01 15:42:04 -0500 | Rating Details | |
2023-04-01 14:15:43 -0500 | Rating Details | |
2023-04-01 16:40:38 -0500 | Rating Details | |
2023-04-01 14:48:26 -0500 | Rating Details | |
2023-04-01 19:17:30 -0500 | Rating Details | |
2023-04-01 15:03:46 -0500 | Rating Details | |
2023-04-01 15:37:25 -0500 | Rating Details | |
2023-04-01 13:39:30 -0500 | Rating Details | |
2023-04-01 11:01:33 -0500 | Rating Details | |
2023-04-01 11:03:05 -0500 | Rating Details | |
2023-04-01 15:59:32 -0500 | Rating Details | |
2023-04-01 13:31:46 -0500 | Rating Details | |
2023-04-01 10:20:07 -0500 | Rating Details | |
2023-04-01 13:52:08 -0500 | Rating Details | |
2023-04-01 13:52:38 -0500 | Rating Details | |
2023-04-01 14:22:59 -0500 | Rating Details | |
2023-04-01 09:58:17 -0500 | Rating Details | |
2023-04-01 10:00:13 -0500 | Rating Details | |
2023-04-01 13:32:37 -0500 | Rating Details | |
2023-04-01 20:08:19 -0500 | Rating Details | |
2023-04-01 14:45:27 -0500 | Rating Details | |
2023-04-01 14:51:16 -0500 | Rating Details | |
2023-04-01 16:07:29 -0500 | Rating Details | |
2023-04-01 14:44:07 -0500 | Rating Details | |
2023-04-01 10:48:32 -0500 | Rating Details | |
2023-04-10 18:34:41 -0500 | Rating Details | |
2023-04-01 10:45:40 -0500 | Rating Details | |
2023-04-01 13:39:47 -0500 | Rating Details | |
2023-04-01 12:51:10 -0500 | Rating Details | |
2023-04-01 16:52:57 -0500 | Rating Details | |
2023-04-01 10:45:02 -0500 | Rating Details |